Henry Schein Q3 Earnings, Sales Climb; Lifts 2026 Adj. Income Outlook

What happened

Henry Schein reported third-quarter fiscal 2026 net income of $119 million, or $1.06 per share, up from $101 million, or $0.84 per share, a year earlier. Net sales rose to $3.471 billion from $3.339 billion, and the company raised its fiscal 2026 adjusted profit outlook.

Confirmed

Global impact / market context

Higher sales and profit mean Henry Schein keeps more cash from each sale, which can fund operations and growth. The raised adjusted profit outlook signals management expects stronger results ahead, which may support the stock and investor confidence in the healthcare products business.

Analyst inference

Henry Schein sells healthcare products and services, so its results reflect demand from dental and medical practices. The guidance includes tariff refunds, which are money back from import taxes, and planned fourth-quarter growth spending. The shares slipped 0.14% to $86.50, a small move after the report.

Analyst inference

What to watch

1. Henry Schein now expects fiscal 2026 adjusted profit of $5.50 to $5.56 per share, above its earlier guidance of $5.29 to $5.39 per share, and reaffirmed total sales growth of 4.5% to 5.5%. Confirmed
2. The company plans targeted and limited growth investments in the fourth quarter, which are spending choices that could raise costs and affect how much profit per sale it reports for the full year. Proposed
3. The outlook depends partly on tariff refunds booked in the third quarter, a one-time benefit. If those refunds do not repeat, future profit growth may rely more on underlying business performance and sales. Analyst inference

Evidence

• Original source link unavailable